CNBC

Squawk Pod

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

Be sure to visit the podcast's website and support the creator: www.cnbc.com

Author

CNBC

Category

Business

Podcast website

www.cnbc.com

Latest episode

Oct 30, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android almost 10M downloads · 4.8 rating iOS soon

Episodes

Biden’s $1.9T Plan; Big Tech’s Next Steps; IPO Fever 15.01.2021

President-Elect Joe Biden has unveiled his $1.9T Covid relief package, and his newly appointed Council of Economic Advisers Member Jared Bernstein makes the case for the proposal and discusses the pandemic’s “dual shock” to the American financial system. The New York Times media columnist Ben Smith joins OZY Media CEO Carlos Watson to examine what comes next for big tech as Silicon Valley giants g...

Ken Langone: I feel betrayed 14.01.2021

In an extended interview, billionaire Republican, Invemed Chairman, and Home Depot co-founder Ken Langone speaks out against reluctance to accept President-Elect Joe Biden as the nation’s next leader. As a trustee of NYU Langone, a philanthropist, and an American billionaire, Langone discusses taxes, pandemic relief, and the country’s public education system. Plus, in a conversation exclusive to S...

Corporate Money Talks…& Walks 13.01.2021

Corporate executives across the country are reassessing their political donations in the wake of last week’s violence in the Capitol. Former EY Global Chairman and CEO Mark Weinberger discusses corporate responsibility amid an increasingly polarized American political environment. Plus, former FDA Commissioner Dr. Scott Gottlieb explains the current vaccine distribution pipeline and considers the...

Vaccine Bottlenecks with Pfizer CEO; Big Tech’s Path Forward with Cambridge Analytica Whistleblower 12.01.2021

Leaders in Washington and on Wall Street are grappling with conservative allegiances as lawmakers approach a vote on impeachment and corporate America cuts off donations to lawmakers who opposed the 2020 Presidential Election results. Cambridge Analytica whistleblower Christopher Wylie discusses the fundamentals of big tech regulation and responsibility with Twitter’s former Global Chair of News a...

The Platform Power Debate: Publishers, Parler, & The President 11.01.2021

Parler, the social app favored by conservative Americans, found itself on the wrong side of Apple, Amazon, and Google in the wake of last week’s riots in the U.S. Capitol. Big tech is drawing a line on the internet, suspending President Donald Trump’s content and forcing Parler temporarily offline. Axios business editor Dan Primack and journalist Joanne Lipman track big tech’s journey to today’s p...

Leadership Amid Chaos: Carlyle’s David Rubenstein & Ariel’s Mellody Hobson 08.01.2021

In the wake of the riots at the Capitol, America’s C-suites are speaking out, some calling for President Trump’s removal from office, others urging a reevaluation and restoration of the United States’ democracy. Founder and co-executive chairman of The Carlyle Group David Rubenstein calls on his fellow business leaders to help restore America’s reputation as a beacon of democracy, and to restore A...

Democracy, the Day After 07.01.2021

Hours after a mob of pro-Trump rioters breached the United States Capitol and disrupted the Presidential certification process, Congress certified President-elect Joe Biden and Vice President-elect Kamala Harris as the nation’s next leaders. On the ground in DC, CNBC’s Washington Reporter Eamon Javers recaps the day’s chaos and the country’s attempt at recovery. President Trump’s former White Hous...

China’s Plans, Georgia’s Polls, Palantir’s Co-Founder, & Sowing Oatly: Planning a Debut 06.01.2021

As Georgia’s final runoff votes are counted, Joe Lonsdale, Palantir co-founder and 8VC founding partner, considers how the state’s races are impacting market volatility. Lonsdale discusses Peloton, Netflix, and other tech stocks on the move as we kick off 2021. Former Fed Governor Kevin Warsh has written a new WSJ op-ed on China’s bid for financial supremacy after President Donald Trump signed an...

2021 Surprises; Jack Ma’s Mystery; An Exchange’s About Face; Haven’s End 05.01.2021

Jack Ma, co-founder of Alibaba, Chinese tech celebrity, and outspoken innovator in China, has not been seen in public for two months. China Beige Book International CEO Leland Miller discusses why the CCP and the Chinese banking sector might be pleased that Ma is lying low. Miller considers the global community’s theories on Ma’s disappearance and what China’s crackdown on tech means for President...

Georgia’s Votes in Focus; WW’s New Year Resolutions 04.01.2021

As the final count in Georgia’s runoff elections draws nearer, Axios co-founder Jim Vandehei breaks down what’s at stake on both sides of the aisle. CNBC’s Eamon Javers recaps the other political story in the Peach State: President Trump’s hour-long call with Georgia’s Secretary of State. American vaccinations are underway, but Dr. Scott Gottlieb considers potential speed bumps in the U.S. supply...

Farewell, 2020: Market Wrap, China’s Progress, & Next Year’s Georgia 31.12.2020

In the final episode of the year, CNBC Beijing Bureau Chief Eunice Yoon shares life in China, a year after the world’s first case of Covid-19 within its borders. CNBC’s Leslie Picker breaks down the most impressive hedge fund returns of the year. Joe Kernen and Becky ring in New Zealand’s New Year together and reflect on the year that was, both emotionally and financially. Looking to 2021, Axios c...

The $2000 Check Debate with Senator Toomey & The $1B+ Club: Unqork 30.12.2020

Senator Pat Toomey (R-PA) shares why he remains against upping the American stimulus checks from $600 to $2000 amid the pandemic. CNBC’s Senior Economics Reporter Steve Liesman breaks down the economic arguments on both sides of the stimulus debate. The United Kingdom has approved the Oxford-AstraZeneca coronavirus vaccine for emergency use, and the shot will join the Pfizer-BioNtech vaccine distr...

Boeing 737 Max Return, & The $1B+ Club: MessageBird 29.12.2020

American Airlines is operating the first U.S. flight of the Boeing 737 Max since the craft was grounded in March or 2019. CNBC’s Auto and Airline Industry Reporter Phil LeBeau is on that first flight from Miami to New York. Plus, EU-based cloud communications platform MessageBird is taking on Twilio with its $3B valuation. In the second interview of the $1B+ Club series, MessageBird CEO Robert Vis...

Ant Group, Intimates, & The $1B+ Club: Klaviyo 28.12.2020

This year has been painful for many businesses, but some tech-focused startups have managed to thrive amid the pandemic. In the $1B+ Club series debut, founder and CEO Klaviyo, Andrew Bialecki, shares how his marketing automation platform quintupled its valuation to $4.15B in the last 10 months. Ping Li, venture capitalist who led Accel’s investment in Klaviyo, discusses how Klaviyo joins a health...

2020: The Year That Was 24.12.2020

In an original conversation exclusive to Squawk Pod, anchors Joe Kernen and Becky Quick reflect on the roller coaster year of the pandemic--market turns, tech glitches, binge watches and all. The two CNBC hosts Zoom in (and out) for a look at what filled their years with gratitude, energy, and hope. Plus, a White Elephant exchange: 2021 predictions, streaming recommendations, and wishes for the ne...

Deal or No Deal with NYT’s Tom Friedman; Vaccines, Strains, & Safety with Dr. Atul Gawande 23.12.2020

After last minute input from President Trump, the $900B relief bill passed by Congress may be back to the negotiating table. The New York Times Columnist Tom Friedman shares why the situation is “suboptimal” across the board, and he discusses what’s next for lawmakers and Americans awaiting aid. Surgeon at Brigham and Women’s Hospital and staff writer for The New Yorker Dr. Atul Gawande discusses...

The Self-Driving Apple of Tim Cook’s Eye, & Relief, “A Christmas Miracle” 22.12.2020

Apple’s efforts to get its own electric passenger vehicle on the road might finally be picking up speed. The Sunday Times West Coast Correspondent Danny Fortson discusses reports that Apple’s taking on Tesla with its own EV, how the tech giant will do it, and why it makes sense. Plus, Congress has finally passed a $900B relief package for Americans. Representatives Josh Gottheimer (D-NJ) and Brian...

Covid’s New Strain; University Tuitions Freezing Over; Tracking Wealth Threats 21.12.2020

New strains of the Covid-19 virus have been found in Britain and South Africa and doctors are warning it could be even more contagious than the original strain. Former FDA commissioner Dr. Scott Gottlieb discusses what a mutated strain of coronavirus means for vaccine efforts and a global recovery. The pandemic has prompted higher education institutions to rethink tuition costs, and Purdue Univers...

(Vaccine) Jabs at the White House 18.12.2020

Vice President Mike Pence received the Pfizer-BioNTech Covid-19 vaccine in a televised appearance today in an effort to boost public confidence in its effectiveness. President-elect Joe Biden could be vaccinated as soon as next week. As the country awaits final approval for Moderna’s Covid-19 vaccine, former FDA Commissioner Dr. Scott Gottlieb raises concerns about the shot supply and volume. CNBC...

HHS Secretary Alex Azar; Media Deal Mogul Aryeh Bourkoff 17.12.2020

As the U.S. works to ensure efficient and effective vaccine distribution, Health and Human Services Secretary Alex Azar urges Americans to remain cautious while they hope for a healthier future. Officials are recommending pared down holiday celebrations, and the first round of vaccine recipients are lining up to get--and showcase--the jab. Plus, the dealmaker behind the Viacom-CBS merger, Verizon’...

Vaccine Rollout; Russian Hack; Who are you Calling Overweight? 16.12.2020

Only 5% to 20% of the coronavirus antibody drugs that have been shipped across the U.S. are being used to treat people who are infected according to CNBC’s Senior Health & Science reporter, Meg Tirrell. Former FDA Commissioner, Dr. Scott Gottlieb. says some states may struggle with last-mile logistics of getting therapeutics to patients and administering Covid vaccines. He said “you’re going to se...

Buffett on Small Business: ‘It’s an economic war’ 15.12.2020

Berkshire Hathaway Chairman Warren Buffett and Goldman Sachs CEO David Solomon address the biggest challenges facing the backbone of the American economy: the thousands of small businesses struggling with no sign of federal relief. “It’s an economic war,” says America’s best-known investor, about the uneven prospects of recovery for smaller firms. Buffett urges Congress to do something - now - and...

D-Day; Pfizer CEO on Vaccine Roll-out: ‘Trust science’ 14.12.2020

An historic day after months of research and clinical trials, the Pfizer-BioNTech Covid vaccine delivery is underway, with millions of doses being distributed across the country. CNBC Senior Health & Science Reporter Meg Tirrell joins Joe Kernen, Becky Quick and Andrew Ross Sorkin with special guest Pfizer CEO, Albert Bourla. Bourla describes the rollout of the life-saving inoculation, reaching do...

I-P-Whoa! Airbnb Takes Off 11.12.2020

Airbnb co-founder and CEO Brian Chesky sat down with Andrew Ross Sorkin ahead of the company’s landmark IPO. Public listings have been on a tear this year in the market’s epic recovery rally from the coronavirus-fueled rout in March. Airbnb, the company that allows users to book short-term rentals and experiences while traveling, jumped 112% during its first day as a public company yesterday. Ches...

CVS Health CEO; “10,000 staffers are ready to vaccinate” & Starbucks’ 2021 Rebound 10.12.2020

The Food and Drug Administration votes today on whether to recommend the approval of Pfizer and BioNTech’s coronavirus vaccine for emergency use. CVS Health Chief Executive Larry Merlo said the company is ready to administer “vaccines into the arms of some of our most vulnerable populations” within 24 to 48 hours upon receiving its share of Covid-19 vaccines. Starbucks lost billions of dollars in...

Listen to the Squawk Pod podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.